Delivery Order SPE2DB22D1200-SPE2DB24FN3KL
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,693.70 and an ultimate completion date of May 6, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $76,007.40. This delivery order contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award does not have a set-aside designation. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract has a ceiling value of $10,341.92 and is for the delivery of the pharmaceutical product ENGERIX-B 20 MCG/ML SYRNML. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,109.88, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,294.13, is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $2,408.46 and a period of performance through May 9, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product, with a potential value of $1,820.64 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there...
This federal contract award, valued at $1,363.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product, with a completion date of May 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,944.61 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,365.70 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...